Digital Health

FDA approves AGENT DCB for coronary artery disease patients

Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for the AGENT Drug-Coated Balloon (DCB), which is indicated to treat coronary in-stent restenosis (ISR) in patients with coronary...
- Advertisement -spot_img

Latest News

Holiday travel rush continues on Sunday

Sunday is expected to be another busy day at Logan airport as people are heading to their holiday destinations. TSA...
- Advertisement -spot_img